Xerostomia: a silent burden for people receiving palliative care - a qualitative descriptive study
- PMID: 39757147
- PMCID: PMC11702030
- DOI: 10.1186/s12904-024-01617-x
Xerostomia: a silent burden for people receiving palliative care - a qualitative descriptive study
Abstract
Background: The prevalence of dry mouth in the palliative care population is well documented and increases due to polypharmacy, radiotherapy and systemic conditions. Saliva as a lubricant for the mouth and throat has implications for swallowing, chewing, and speech. The literature about the experience of xerostomia (perceived feeling of dry mouth) in palliative care is scarce. Clinical evidence suggests that xerostomia has a negative impact on people's comfort, however, no recent studies explored this impact in detail. This new knowledge is paramount to adhere to the principles of palliative care.
Aims: To evaluate the impact of xerostomia on the lives of people receiving palliative care with particular reference to eating and speaking. DESIGN: A qualitative descriptive study (interview design). Thematic analysis was used for data analysis.
Setting: A single specialist palliative care centre in Ireland.
Results: The majority of participants (35/40) had cancer. Xerostomia was reported to have multiple physical, psychological, and daily life consequences. Participants provided insights into the impact of xerostomia on sleeping, eating, talking, denture wearing, and they described in detail their intra-oral sensations associated with xerostomia. The negative effect of xerostomia on speech was reported as the most significant to participants.
Conclusion: Xerostomia has a profound impact on the daily lives of people receiving palliative care, including physical and psychological consequences. Speaking is often affected, which can impede the person's ability to communicate. There needs to be increased awareness of the impact of xerostomia and more research is required to understand how best to manage xerostomia in a palliative care setting.
Keywords: Dry mouth; Palliative care; Qualitative; Xerostomia.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical approval (ECM(00)14/01/2020) was received from the Clinical Research Ethics Committee Cork Teaching Hospitals and the Munster Technological University. All participants were carefully selected and provided with a written study information leaflet. Participants were made aware, both verbally and in the participant information leaflet, that they could withdraw from the process at any stage. Procedures for informed consent and careful storage of all data adhered to the guidelines of the Ethics Committees and General Data Protection Regulations. Consent for publication: All authors give their consent for publication of this manuscript. Competing interests: The authors declare no competing interests.
Similar articles
-
Physical and psychosocial impact of xerostomia in palliative cancer care: a qualitative interview study.Int J Palliat Nurs. 2002 Jul;8(7):318-23. doi: 10.12968/ijpn.2002.8.7.10671. Int J Palliat Nurs. 2002. PMID: 12165715
-
[Xerostomia in palliative care].Acta Med Port. 2005 Nov-Dec;18(6):459-65. Epub 2006 Mar 6. Acta Med Port. 2005. PMID: 16684486 Review. Portuguese.
-
Palliative care assessment of dry mouth: what matters most to patients with advanced disease?Support Care Cancer. 2020 Mar;28(3):1121-1129. doi: 10.1007/s00520-019-04908-9. Epub 2019 Jun 14. Support Care Cancer. 2020. PMID: 31201546 Free PMC article.
-
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809. JBI Database System Rev Implement Rep. 2015. PMID: 26447011
-
Xerostomia--a review.Palliat Med. 1996 Oct;10(4):284-92. doi: 10.1177/026921639601000403. Palliat Med. 1996. PMID: 8931063 Review.
Cited by
-
Drug-induced xerostomia and hyposalivation in patients with overactive bladder: a prospective open-label observational study comparing antimuscarinics and β3-adrenoceptor agonists.Sci Rep. 2025 Jul 9;15(1):24758. doi: 10.1038/s41598-025-09720-6. Sci Rep. 2025. PMID: 40634504 Free PMC article.
References
-
- Kvalheim SF, Strand GV, Husebø BS, et al. End-of‐life palliative oral care in Norwegian health institutions - an exploratory study. Gerodontology. 2015;33:522–9. - PubMed
-
- Mercadante S, Aielli F, Adile C, et al. Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer. 2015;23:3249–55. - PubMed
-
- Saito M, Shimazaki Y, Nonoyama T, et al. Association of oral health factors related to oral function with mortality in older Japanese. Gerodontology. 2020;38:166–73. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical